Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new Publications section was added showing the NEJM 2025 article on pegcetacoplan in C3G/IC-MPGN and a PubMed auto-fill note.
    Difference
    0.1%
    Check dated 2025-12-09T01:22:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A minor maintenance update is shown: Revision v3.3.2 was added and Revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T20:57:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice banner. The study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T18:13:21.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Results for NCT05067127 were posted on ClinicalTrials.gov (Results First Posted 2025-08-06). The posted results include primary and several secondary outcomes, such as changes in urine protein-to-creatinine ratio (uPCR) and estimated glomerular filtration rate (eGFR).
    Difference
    0.2%
    Check dated 2025-11-03T12:53:39.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:34:42.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Minor version update added; several drug-safety and pharmaceutical topics were removed, narrowing the page’s scope around medications and safety topics.
    Difference
    0.6%
    Check dated 2025-09-28T10:48:51.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.